Discontinued — last reported Q2 '20
An increase signals that previous investments in intangible assets are underperforming or becoming obsolete.
This represents the write-down of the carrying value of finite-lived intangible assets, such as patents or customer list...
Common in R&D-heavy industries like pharmaceuticals and biotech.
zts_segment_material_reconciling_items_impairment_of_intangible_assets_finitelived